LEXICON PHARMACEUTICALS INC (LXRX) Stock Analyst Earnings Estimates
NASDAQ:LXRX - Nasdaq - US5288723027 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | 300K -98.75% | 100K -66.67% | 1.204M 1,104.00% | 11.353M 842.94% | 13.596M 19.76% | 27.46M 101.97% | 76.417M 178.28% | 192.49M 151.89% | 471.14M 144.76% | 699.32M 48.43% | 970.8M 38.82% | 1.268B 30.61% | |
| EBITDA YoY % growth | -86.8M 50.65% | -100.4M -15.67% | -171.196M -70.51% | -228.073M -33.22% | -169.44M 25.71% | -158.872M 6.24% | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -87.1M 51.29% | -100.8M -15.73% | -171.75M -70.39% | -216.185M -25.87% | -170.986M 20.91% | -164.265M 3.93% | -151.691M 7.65% | -67.099M 55.77% | 286.07M 526.34% | 562.38M 96.59% | 903.74M 60.70% | 1.297B 43.51% | |
| Operating Margin | -29,033.33% | -100,800.00% | -14,264.95% | -1,904.21% | -1,257.62% | -598.20% | -198.50% | -34.86% | 60.72% | 80.42% | 93.09% | 102.29% | |
| EPS YoY % growth | -0.61 -1.67% | -0.61 0.00% | -0.80 -31.15% | -0.70 12.15% | -0.48 31.86% | -0.42 11.61% | -0.33 21.28% | 0.08 122.96% | 0.79 926.67% | 1.54 96.10% | 1.93 25.17% | 2.41 24.87% |
All data in USD
| Q4 / 24 | Q1 / 25 | Q2 / 25 | Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.13 35.06% | -0.13 37.10% | -0.13 24.00% | -0.13 26.33% | -0.13 0.52% | -0.16 -29.73% | -0.16 -26.31% | -0.16 -23.08% | -0.17 -34.21% |
| Revenue Q2Q % growth | 6.61M 841.60% | 3.111M 175.31% | 3.941M 139.28% | 5.783M 230.46% | 8.303M 25.61% | 18.391M 491.16% | 20.278M 414.54% | 25.765M 345.53% | 21.369M 157.36% |
| EBITDA Q2Q % growth | -60.955M -31.99% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -49.892M -6.75% | -44.342M 2.19% | -46.641M 15.74% | -47.97M 24.69% | -49.126M 1.54% | -59.035M -33.13% | -61.067M -30.93% | -57.739M -20.37% | -63.849M -29.97% |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | -0.18 14.29% | -0.17 | -0.01 | -7.28% |
| Q2 2024 Q2Q % growth | -0.17 22.73% | -0.19 | 0.02 | 11.66% |
| Q1 2024 Q2Q % growth | -0.20 -17.65% | -0.20 | 0.00 | 0.72% |
| Q4 2023 Q2Q % growth | -0.20 -25.00% | -0.22 | 0.02 | 9.75% |
| Q3 2023 Q2Q % growth | -0.21 -61.54% | -0.22 | 0.01 | 4.13% |
| Q2 2023 Q2Q % growth | -0.22 -37.50% | -0.18 | -0.04 | -23.43% |
| Q1 2023 Q2Q % growth | -0.17 -6.25% | -0.18 | 0.01 | 7.02% |
| Q4 2022 Q2Q % growth | -0.16 5.88% | -0.14 | -0.02 | -17.06% |
| Q3 2022 Q2Q % growth | -0.13 18.75% | -0.14 | 0.01 | 8.53% |
| Q2 2022 Q2Q % growth | -0.16 -23.08% | -0.16 | 0.00 | 0.30% |
| Q1 2022 Q2Q % growth | -0.16 -6.67% | -0.17 | 0.01 | 4.74% |
| Q4 2021 Q2Q % growth | -0.17 -325.00% | -0.19 | 0.02 | 8.76% |
| Q3 2021 Q2Q % growth | -0.16 -122.86% | -0.18 | 0.02 | 11.38% |
| Q2 2021 Q2Q % growth | -0.13 79.37% | -0.16 | 0.03 | 20.22% |
| Q1 2021 Q2Q % growth | -0.15 76.19% | -0.16 | 0.01 | 6.57% |
| Q4 2020 Q2Q % growth | -0.04 91.67% | -0.28 | 0.24 | 85.82% |
| Q3 2020 Q2Q % growth | 0.70 -66.82% | 0.27 | 0.43 | 160.20% |
| Q2 2020 Q2Q % growth | -0.63 -186.36% | -0.62 | -0.01 | -1.63% |
| Q1 2020 Q2Q % growth | -0.63 -200.00% | -0.71 | 0.08 | 11.08% |
| Q4 2019 Q2Q % growth | -0.48 | -0.79 | 0.31 | 39.00% |
| Q3 2019 Q2Q % growth | 2.11 | 0.74 | 1.37 | 183.84% |
| Q2 2019 Q2Q % growth | -0.22 | -0.08 | -0.14 | -180.11% |
| Q1 2019 Q2Q % growth | -0.21 | -0.23 | 0.02 | 7.68% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2024 Q2Q % growth | 1.75M 980.25% | 2.988M | -1.238M | -41.43% |
| Q2 2024 Q2Q % growth | 1.647M 419.56% | 2.887M | -1.24M | -42.95% |
| Q1 2024 Q2Q % growth | 1.13M 4,608.33% | 1.429M | -299K | -20.92% |
| Q4 2023 Q2Q % growth | 702K | 1.267M | -565K | -44.59% |
| Q3 2023 Q2Q % growth | 162K | 2.101M | -1.939M | -92.29% |
| Q2 2023 Q2Q % growth | 317K | 68.003K | 248.997K | 366.15% |
| Q1 2023 Q2Q % growth | 24K | 33.997K | -9.997K | -29.40% |
| Q4 2022 Q2Q % growth | 51K | -51K | -100.00% | |
| Q3 2022 Q2Q % growth | 51K | -51K | -100.00% | |
| Q2 2022 Q2Q % growth | -100.00% | 51K | -51K | -100.00% |
| Q1 2022 Q2Q % growth | 51K | -51K | -100.00% | |
| Q4 2021 Q2Q % growth | -100.00% | % | ||
| Q3 2021 Q2Q % growth | -100.00% | % | ||
| Q2 2021 Q2Q % growth | 200K -97.83% | 9.18K | 190.82K | 2,078.65% |
| Q1 2021 Q2Q % growth | -100.00% | 1.71M | -1.71M | -100.00% |
| Q4 2020 Q2Q % growth | 200K -97.70% | 112.2K | 87.8K | 78.25% |
| Q3 2020 Q2Q % growth | 6.6M -97.76% | 17.21M | -10.61M | -61.65% |
| Q2 2020 Q2Q % growth | 9.2M -5.15% | 9.006M | 194K | 2.15% |
| Q1 2020 Q2Q % growth | 8M -13.04% | 7.944M | 56K | 0.70% |
| Q4 2019 Q2Q % growth | 8.7M | 10.471M | -1.771M | -16.91% |
| Q3 2019 Q2Q % growth | 294.4M | 65.535M | 228.865M | 349.23% |
| Q2 2019 Q2Q % growth | 9.7M | 29.089M | -19.389M | -66.65% |
| Q1 2019 Q2Q % growth | 9.2M | 13.532M | -4.332M | -32.01% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | 0% | -2.41% | 0% | -1.47% |
| Revenue | 0% | -7.33% | 0% | -4.4% |